Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:08:20 EDT Sun 17 Aug 2025
Enter Symbol
or Name
USA
CA



Q:CYTK - CYTOKINETICS INC - https://www.cytokinetics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CYTK - Q0.137.82·39.520.138.67-0.05-0.11,214.045,89714,34038.92  39.0955  37.7959.39  29.3119:57:49Aug 0715 min RT 2¢

Recent Trades - Last 10 of 14340
Time ETExPriceChangeVolume
19:57:49Q39.200.481
19:51:08Q39.50640.7864400
19:30:04Q39.200.481
19:29:20Q39.200.481
19:27:41Q39.500.78100
19:27:41Q39.430.711
19:27:41Q39.42990.70991
19:26:17Q39.200.4826
19:26:17Q39.200.48100
19:25:26Q39.200.4885

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-08-07 16:00U:CYTKNews ReleaseCytokinetics Reports Second Quarter 2025 Financial Results and Provides Business Update
2025-07-24 16:00U:CYTKNews ReleaseCytokinetics to Announce Second Quarter Results On August 7, 2025
2025-07-18 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
2025-07-10 07:30U:CYTKNews ReleaseCytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025
2025-06-17 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-06-10 07:30U:CYTKNews ReleaseCytokinetics Announces Call For Proposals For Annual Corporate Giving Program
2025-05-29 16:01U:CYTKNews ReleaseCytokinetics to Participate in the Jefferies Global Healthcare Conference
2025-05-18 08:00U:CYTKNews ReleaseCytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress
2025-05-16 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-05-15 07:30U:CYTKNews ReleaseCytokinetics to Host Symposium on Contemporary Landscapes in Muscle Biology
2025-05-13 07:30U:CYTKNews ReleaseCytokinetics Announces Positive Topline Results From MAPLE-HCM
2025-05-08 16:00U:CYTKNews ReleaseCytokinetics Announces Four Upcoming Presentations at the European Society Of Cardiology Heart Failure 2025 Congress
2025-05-07 16:00U:CYTKNews ReleaseCytokinetics to Hold Annual Meeting of Stockholders
2025-05-06 16:00U:CYTKNews ReleaseCytokinetics Reports First Quarter 2025 Financial Results and Provides Business Update
2025-05-01 16:15U:CYTKNews ReleaseCytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy
2025-04-30 16:00U:CYTKNews ReleaseCytokinetics to Participate in May Investor Conferences
2025-04-22 16:00U:CYTKNews ReleaseCytokinetics to Announce First Quarter Results on May 6, 2025
2025-04-17 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-03-31 16:00U:CYTKNews ReleaseCytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference
2025-03-20 07:30U:CYTKNews ReleaseCytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community